Integrated clinical, genetic and functional analysis of the ABCA4 locus

ABCA4 基因座的综合临床、遗传和功能分析

基本信息

  • 批准号:
    10382301
  • 负责人:
  • 金额:
    $ 42.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Mutations in the ABCA4 gene are responsible for a wide variety of retinal degeneration phenotypes, including Stargardt disease (STGD), cone-rod dystrophy (CRD) and retinitis pigmentosa (RP). Different combinations of >900 ABCA4 mutant alleles result in distinct phenotypes in a continuum of disease manifestations. Variation in the ABCA4 locus has emerged as the most prevalent cause of Mendelian retinal disease, with an estimated 1/20 people across all populations carrying a potential disease-associated variant in this gene. Genetic analyses of ABCA4-associated retinal disease have been substantially advanced in recent years. New methods, such as direct sequencing of the entire genomic ABCA4 locus, have allowed detecting up to 80% of the disease-associated ABCA4 alleles, including 2 (both) mutations in ~65-75% of patients. Of these 75% are in the coding region and 25% in introns, more than half of which are outside of splice consensus sequences. Of the rest, 1 mutation is detected in ~20% of patients while no disease-associated alleles are found in another 10% of screened patients with phenotypes compatible with the ABCA4 disease. These data suggest that many (rare) disease-associated ABCA4 alleles are yet to be identified and, most importantly, unequivocally confirmed by adequate functional analyses. We will test the hypothesis that a combination of advanced genetic screening coupled with advanced functional analyses of ABCA4 alleles from non-coding sequences is necessary to unequivocally determine the ABCA4-associated disease load. The proposed research program, based on large, comprehensively characterized familial cohort of ABCA4 disease, is using integrated approaches of genetic analyses, quantified clinical data and functional analyses to generate a predictive model for ABCA4 disease. The ultimate goal of the proposed project is to complete the analysis of the ABCA4 locus. The research program is organized into two Specific Aims. In the first Aim, we propose a novel combinatorial pipeline utilizing our existing clinical and genetic databases, accumulated knowledge, and advanced in silico methodology to predict most disease-associated variants in the coding and non-coding sequences of the entire ABCA4 locus. In the second Aim we will confirm or reject the variants in non-coding sequences for disease association by functional testing ABCA4 RNA from mutated iPSC lines for splicing and expression defects. The outcome of these studies will substantially aid in disease diagnosis, prognosis and will serve as a platform for selecting patients for emerging clinical trials geared to delay the onset, or arrest the progression, of ABCA4-associated diseases.
ABCA4基因的突变导致了多种视网膜变性表型,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RANDO L ALLIKMETS其他文献

RANDO L ALLIKMETS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RANDO L ALLIKMETS', 18)}}的其他基金

Integrated clinical, genetic and functional analysis of the ABCA4 locus
ABCA4 基因座的综合临床、遗传和功能分析
  • 批准号:
    10636782
  • 财政年份:
    2019
  • 资助金额:
    $ 42.08万
  • 项目类别:
Stargardt disease with low lipofuscin
脂褐质低的 Stargardt 病
  • 批准号:
    10361403
  • 财政年份:
    2019
  • 资助金额:
    $ 42.08万
  • 项目类别:
Integrated clinical, genetic and functional analysis of the ABCA4 locus
ABCA4 基因座的综合临床、遗传和功能分析
  • 批准号:
    10155493
  • 财政年份:
    2019
  • 资助金额:
    $ 42.08万
  • 项目类别:
Precision medicine for ABCA4 disease: modifier alleles
ABCA4 疾病的精准医学:修饰等位基因
  • 批准号:
    10203998
  • 财政年份:
    2018
  • 资助金额:
    $ 42.08万
  • 项目类别:
Completing genetic analysis of the ABCA4 locus
完成 ABCA4 位点的遗传分析
  • 批准号:
    8658084
  • 财政年份:
    2011
  • 资助金额:
    $ 42.08万
  • 项目类别:
Therapeutic approaches for ABCA4-associated disorders
ABCA4 相关疾病的治疗方法
  • 批准号:
    8300072
  • 财政年份:
    2011
  • 资助金额:
    $ 42.08万
  • 项目类别:
Completing genetic analysis of the ABCA4 locus
完成 ABCA4 位点的遗传分析
  • 批准号:
    8024019
  • 财政年份:
    2011
  • 资助金额:
    $ 42.08万
  • 项目类别:
Therapeutic approaches for ABCA4-associated disorders
ABCA4 相关疾病的治疗方法
  • 批准号:
    8018761
  • 财政年份:
    2011
  • 资助金额:
    $ 42.08万
  • 项目类别:
Completing genetic analysis of the ABCA4 locus
完成 ABCA4 位点的遗传分析
  • 批准号:
    8443427
  • 财政年份:
    2011
  • 资助金额:
    $ 42.08万
  • 项目类别:
Therapeutic approaches for ABCA4-associated disorders
ABCA4 相关疾病的治疗方法
  • 批准号:
    8523886
  • 财政年份:
    2011
  • 资助金额:
    $ 42.08万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.08万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了